Closure device or manual compression in patients undergoing percutaneous coronary intervention: A randomized comparison

Journal of Invasive Cardiology

Volumn 22, Issue 12, 2010, Pages 562-566

  Hermanides, Renicus S ^a   Ottervanger, Jan Paul ^a   Dambrink, Jan Henk E ^a   De Boer, Menko Jan ^a   Hoorntje, Jan C A ^a   Gosselink, A T Marcel ^a   Suryapranata, Harry ^a   Van'T Hof, Arnoud W J ^a  

^a ISALA HOSPITAL   (Netherlands)

Author keywords

Angio Seal; closure device; manual compression; PCI; triple antiplatelet therapy

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TIROFIBAN;

ADOLESCENT; ADULT; ARTERIOVENOUS FISTULA; ARTICLE; BLEEDING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FEMORAL ARTERY; HEMATOMA; HOSPITALIZATION; HUMAN; HYPERTENSION; INGUINAL REGION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MANUAL COMPRESSION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; VASCULAR ACCESS DEVICE; VASCULAR CLOSURE DEVICE; WOUND CLOSURE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ARTERIOVENOUS FISTULA; CORONARY VESSELS; FEMALE; FEMORAL ARTERY; HEMATOMA; HEMORRHAGE; HEMOSTASIS, SURGICAL; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PRESSURE; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; TREATMENT OUTCOME; WOUND CLOSURE TECHNIQUES;

EID: 79551507294     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Resnic FS, Blake G, Ohno-Machado L, et al. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol 2001;88:493-496.
2. Omoigui N, Califf R, Pieper KS, et al. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Artherectomy Trial (CAVEAT-I). J Am Coll Cardiol 1995;26:922-930.
3. Oweida SW, Roubin, GS, Smith RB 3rd, Salam AA. Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty. J Vasc Surg 1990;12:310-315.
4. McCann Rl, Schwartz LB, Pieper KS. Vascular complications of cardiac catheterization. J Vasc Surg 1991;14:375-381.
5. Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992;69:63-68.
6. Lenderink T, Boersma E, Ruzyllo W, et al. GUSTO IV-ACS investigators. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS. Am Heart J 2004;147:865-873.
7. Ellis SG, Elliot J, Horrigan M, et al. Low-normal or excessive body mass index: Newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol 1996;78:642-646.
8. Waksman R, King SB, Douglas JS, et al. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995;75:886-889.
9. Dangas G, Mehran R, Kokolis S, et al. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 2001;38:638-641.
10. Juergens CP, Leung DY, Crozier JA, et al. Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention. Catheter Cardiovasc Interv 2004;63:166-170.
11. Koreny M, Riedmuller E, Nikfardjam M, et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization. JAMA 2004;291:350-357.
12. Vaitkus PT. A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol 2004;16:243-246.
13. Exaire JE, Dauermann HL, Topol EJ, et al, for the TARGET investigators. Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices. Am Heart J 2004;147:31-34.
14. Boccalandro F, Assali A, Fujise K, et al. Vascular access site complications with the use of closure devices in patients treated with platelet glycoprotein IIb/IIIa inhibitors during rescue angioplasty. Cather Cardiovasc Interv 2004;63:284-289.
15. Rapaport S, Sniderman KW, Morse SS, et al. Pseudoaneurysm: A complication of faulty technique in femoral arterial puncture. Radiology 1985;154:529-530.
16. Silber S, Albertsson P, Avilés FF, et al. ESC guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-847.
17. Hermanides RS, Ottervanger JP, Dambrink JHE, et al. Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction. Eurointervention 2010;6:106-111.
18. Cura FA, Kapadia SR, L'Allier PL, et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol 2000;86:780-782.
19. Applegate RJ, Grabarczyk MA, Little WC, et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol 2002;40:78-83.
20. Nikolsky E, Mehran E, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: A meta-analysis. J Am Coll Cardiol 2004;44:1200-1209.
21. Chevalier B, Lancelin B, Koning R, et al. HEMOSTASE trial investigators. Effect of a closure device on complication rates in high local risk patients: Results of a randomized multicenter trial. Catheter Cardiovasc Interv 2003;58:285-291.
22. Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: Implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv 2005;65:196-202.
23. Jacobi JA, Schussler JM, Johnson KB. Routine femoral head fluoroscopy to reduce complications in coronary catheterization. Proc (Bayl Univ Med Cent) 2009;22:7-8.
24. Turi ZG. It?s time to seal every artery but?comparing apples and oranges in the vascular sealing literature. Catheter Cardiovasc Interv 2001;53:443-444.
25. Eggebrecht H, Erbel R. Recommendations for future trials in the field of access site closure: focusing on clinically significant endpoints. Catheter Cardiovasc Interv 2002;55:525-526.
26. Turi ZG. Ooze you lose: II, are we really getting better all the time? Catheter Cardiovasc Interv 2002;57:484-485.
27. Niederstadt JA. Frequency and timing of activated clotting time levels for sheath removal. J Nurs Care Qual 2004;19:34-38.
28. Narins CR, Zareba W, Rocco V, McNitt S. A prospective, randomized trial of topical hemostasis patch use following percutaneous coronary and peripheral intervention. J Invasive Cardiol 2008;20:579-584.
29. Dumont CJ. Blood pressure and risks of vascular complications after percutaneous coronary intervention. Dimens Crit Care Nurs 2007;26:121-127.